Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Other Non Operating Income (2016 - 2025)

Haemonetics has reported Other Non Operating Income over the past 17 years, most recently at -$7.4 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$7.4 million for Q4 2025, up 18.56% from a year ago — trailing twelve months through Dec 2025 was -$23.9 million (down 52.63% YoY), and the annual figure for FY2025 was -$9.7 million, up 25.13%.
  • Other Non Operating Income for Q4 2025 was -$7.4 million at Haemonetics, down from -$7.2 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for HAE hit a ceiling of $7.0 million in Q2 2024 and a floor of -$9.1 million in Q4 2024.
  • Median Other Non Operating Income over the past 5 years was -$4.5 million (2021), compared with a mean of -$4.2 million.
  • Peak annual rise in Other Non Operating Income hit 436.25% in 2024, while the deepest fall reached 367.52% in 2024.
  • Haemonetics' Other Non Operating Income stood at -$4.6 million in 2021, then skyrocketed by 77.01% to -$1.1 million in 2022, then crashed by 84.74% to -$1.9 million in 2023, then tumbled by 367.52% to -$9.1 million in 2024, then rose by 18.56% to -$7.4 million in 2025.
  • The last three reported values for Other Non Operating Income were -$7.4 million (Q4 2025), -$7.2 million (Q3 2025), and -$8.7 million (Q2 2025) per Business Quant data.